116
Views
12
CrossRef citations to date
0
Altmetric
Review

The role of genetics in pre-eclampsia and potential pharmacogenomic interventions

&
Pages 37-51 | Published online: 20 Jan 2012

References

  • RedmanCWPreeclampsia: a multi-stress disorderRev Med Interne201132Suppl 1S41S4421530020
  • VillarKSayLGulmezogluAMEclampsia and pre-eclampsia: a health problem for 2,000 yearsCritchleyHMacLeanABPostonLWalkerJJPreeclampsiaLondonRCOG Press2003189207
  • KajantieEErikssonJGOsmondCThornburgKBarkerDJPre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort studyStroke20094041176118019265049
  • BauerSTClearyKLCardiopulmonary complications of pre-eclampsiaSemin Perinatol200933315816519464506
  • ZeemanGGNeurologic complications of pre-eclampsiaSemin Perinatol200933316617219464507
  • RobertsJMHubelCAThe two stage model of preeclampsia: variations on the themePlacenta200930Suppl AS32S3719070896
  • RedmanCWSargentILPlacental stress and pre-eclampsia: a revised viewPlacenta200930Suppl AS38S4219138798
  • RedmanCWSargentILImmunology of pre-eclampsiaAm J Reprod Immunol201063653454320331588
  • BrownMALindheimerMDde SwietMVan AsscheAMoutquinJMThe classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Hypertens Pregnancy2001201IXXIV12044323
  • RobertsJMRedmanCWPre-eclampsia: more than pregnancy-induced hypertensionLancet19933418858144714518099148
  • McCarthyALTaylorPGravesJRajuSKPostonLEndothelium-dependent relaxation of human resistance arteries in pregnancyAm J Obstet Gynecol19941715130913157977539
  • WardKLindheimerMDGenetic factors in the etiology of preec-lampsia/eclampsiaLindheimerMDRobertsJMCunninghamFDChesley’s Hypertensive Disorders in PregnancyLondonElsevier20095172
  • CoxBSharmaPEvangelouAITranslational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsiaMol Cell Proteomics20111012M111.012526
  • ViannaPBauerMEDornfeldDChiesJADistress conditions during pregnancy may lead to pre-eclampsia by increasing cortisol levels and altering lymphocyte sensitivity to glucocorticoidsMed Hypotheses201177218819121550175
  • RobinsonCJAlanisMCWagnerCLHollisBWJohnsonDDPlasma 25-hydroxyvitamin D levels in early-onset severe preeclampsiaAm J Obstet Gynecol2010203436620692641
  • CooperDWBrenneckeSPWiltonANGenetics of pre-eclampsiaHypertens Pregnancy199312123
  • FisherSJMcMasterMRobertsJMThe placenta in normal pregancy and preeclampsiaLindheimerMDRobertsJMCunninghamFDChesley’s Hypertensive Disorders in PregnancyLondonElsevier20097386
  • KurdogluMKurdogluZOzenSExpression of laminin receptor 1 in human placentas from normal and preeclamptic pregnancies and its relationship with the severity of preeclampsiaJ Perinat Med201139441141621391874
  • SkjaervenRVattenLJWilcoxAJRonningTIrgensLMLieRTRecurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohortBMJ2005331752187716169871
  • HaigDGenetic conflicts in human pregnancyQ Rev Biol19936844955328115596
  • GOPEC ConsortiumDisentangling fetal and maternal susceptibility for pre-eclamspia: a British multicenter candidate-gene studyAm J Hum Genet20057712713115889386
  • DekkerGRobillardPYRobertsCThe etiology of preeclampsia: the role of the fatherJ Reprod Immunol201189212613221529966
  • AinsworthHFUnwinJJamisonDLCordellHJInvestigation of maternal effects, maternal-fetal interactions and parent-of-origin effects (imprinting), using mothers and their offspringGenet Epidemiol2011351194521181895
  • MutzeSRudnik-SchonebornSZerresKRathWGenes and the preeclampsia syndromeJ Perinat Med2008361385818184097
  • de MaatMPde GrootCJThrombophilia and pre-eclampsiaSemin Thromb Hemost201137210611021370209
  • IsermannBSoodRPawlinskiRThe thrombomodulin-protein C system is essential for the maintenance of pregnancyNat Med20039333133712579195
  • DalmazCASantosKGBottonMRTedoldiCLRoisenbergIRelationship between polymorphisms in thrombophilic genes and pre-eclampsia in a Brazilian populationBlood Cells Mol Dis200637210711016963292
  • GerhardtAGoeckeTWBeckmannMWThe G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsiaJ Thromb Haemost20053468669115842353
  • LinJAugustPGenetic thrombophilias and preeclampsia: a meta-analysisObstet Gynecol2005105118219215625161
  • RodgerMABetancourtMTClarkPThe association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studiesPLoS Med201076e100029220563311
  • MedicaIKastrinAPeterlinBGenetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysisEur J Obstet Gynecol Reprod Biol2007131211512617112651
  • ZafarmandMHNijdamMEFranxAGrobbeeDEBotsMLThe angiotensinogen gene M235T polymorphism and development of preeclampsia/eclampsia: a meta-analysis and meta-regression of observational studiesJ Hypertens20082691726173418698203
  • BrenneckeSPGudeNMDi IulioJLKingRGReduction of placental nitric oxide synthase activity in pre-eclampsiaClin Sci (Lond)199793151559279203
  • PapazoglouDGalaziosGKoukourakisMIVascular endothelial growth factor gene polymorphisms and pre-eclampsiaMol Hum Reprod200410532132414997002
  • BowerCStanleyFWaltersBNPre-eclampsia and trisomy 13Lancet19872856610322889946
  • ChenCPPlacental abnormalities and preeclampsia in trisomy 13 pregnanciesTaiwan J Obstet Gynecol20094813819346185
  • BurtonGJJauniauxEOxidative stressBest Pract Res Clin Obstet Gynaecol201125328729921130690
  • JauniauxEPostonLBurtonGJPlacental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolutionHum Reprod Update200612674775516682385
  • FoidartJMHustinJDuboisMSchaapsJPThe human placenta becomes haemochorial at the 13th week of pregnancyInt J Dev Biol19923634514531445791
  • WalkerJJAntioxidants and inflammatory cell response in preeclampsiaSemin Reprod Endocrinol199816147559654607
  • MistryHDKurlakLOWilliamsPJRamsayMMSymondsMEPipkinFBDifferential expression and distribution of placental glutathione peroxidases 1, 3 and 4 in normal and preeclamptic pregnancyPlacenta201031540140820303587
  • WickensDWilkinsMHLunecJBallGDormandyTLFree radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancyAnn Clin Biochem198118Pt 31581627283366
  • CantoPCanto-CetinaTJuarez-VelazquezRMethylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo womenHypertens Res20083151015101918712057
  • GebhardtGSPetersWHHillermannRMaternal and fetal single nucleotide polymorphisms in the epoxide hydrolase and gluthatione S-transferase P1 genes are not associated with pre-eclampsia in the Coloured population of the Western Cape, South AfricaJ Obstet Gynaecol200424886687216147638
  • LaasanenJRomppanenELHiltunenMTwo exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsiaEur J Hum Genet200210956957312173035
  • DescampsOSBruniauxMGuilmotPFTongletRHellerFRLipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn childrenJ Lipid Res200546112405241416106048
  • KimYJWilliamsonRAChenKSmithJLMurrayJCMerrillDCLipoprotein lipase gene mutations and the genetic susceptibility of preeclampsiaHypertension200138599299611711487
  • AtkinsonKRBlumensteinMBlackMAAn altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsiaJ Lipid Res2009501718018725658
  • ZhangCAustinMAEdwardsKLFunctional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian womenClin Genet2006691333916451134
  • WangJXKnottnerusAMSchuitGNormanRJChanADekkerGASurgically obtained sperm, and risk of gestational hypertension and pre-eclampsiaLancet2002359930767367411879865
  • KlatskyPCDelaneySSCaugheyABTranNDSchattmanGLRosenwaksZThe role of embryonic origin in preeclampsia: a comparison of autologous in vitro fertilization and ovum donor pregnanciesObstet Gynecol201011661387139221099607
  • BulmerJNWilliamsPJLashGEImmune cells in the placental bedInt J Dev Biol2010542–328129419876837
  • HibySEWalkerJJO’ShaughnessyKMCombinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive successJ Exp Med2004200895796515477349
  • SharmaASatyamASharmaJBLeptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant womenAm J Reprod Immunol2007581213017565544
  • AlexanderBTCockrellKLMasseyMBBennettWAGrangerJPTumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expressionAm J Hypertens2002152 Pt 117017511863253
  • ElahiMMAsotraKMatataBMMastanaSSTumor necrosis factor alpha 308 gene locus promoter polymorphism: an analysis of association with health and diseaseBiochim Biophys Acta20091792316317219708125
  • SaarelaTHiltunenMHelisalmiSHeinonenSLaaksoMTumour necrosis factor-alpha gene haplotype is associated with pre-eclampsiaMol Hum Reprod200511643744015901845
  • BombellSMcGuireWTumour necrosis factor (308A) polymorphism in pre-eclampsia: meta-analysis of 16 case-control studiesAust N Z J Obstet Gynaecol200848654755119133041
  • RenaudSJMacdonald-GoodfellowSKGrahamCHCoordinated regulation of human trophoblast invasiveness by macrophages and interleukin 10Biol Reprod200776344845417151353
  • MakrisAXuBYuBThorntonCHennessyAPlacental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphismPlacenta2006274–544545116026832
  • DaherSSassNOliveiraLGMattarRCytokine genotyping in preeclampsiaAm J Reprod Immunol200655213013516433832
  • GoddardKATrompGRomeroRCandidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genesHum Hered200763111617179726
  • CarterAMPijnenborgREvolution of invasive placentation with special reference to non-human primatesBest Pract Res Clin Obstet Gynaecol201125324925721056010
  • KanasakiKPalmstenKSugimotoHDeficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsiaNature200845371981117112118469803
  • BergDSonsallaRKussEConcentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labelled ligandActa Endocrinol (Copenh)198310322822886858558
  • SataFYamadaHSuzukiKFunctional maternal catechol-O-methyltransferase polymorphism and fetal growth restrictionPharmacogenet Genomics2006161177578117047485
  • ArngrimssonRSigurard ttirSFriggeMLA genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13Hum Mol Genet1999891799180510441346
  • LaivuoriHLahermoPOllikainenVSusceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish familiesAm J Hum Genet200372116817712474145
  • MosesEKLadeJAGuoGA genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2Am J Hum Genet20006761581158511035632
  • LachmeijerAMArngrimssonRBastiaansEJA genome-wide scan for preeclampsia in the NetherlandsEur J Hum Genet200191075876411781687
  • ZintzarasEKitsiosGHarrisonGAHeterogeneity-based genome search meta-analysis for preeclampsiaHum Genet2006120336037016868762
  • AkolekarREtchegarayAZhouYMaizNNicolaidesKHMaternal serum activin a at 11–13 weeks of gestation in hypertensive disorders of pregnancyFetal Diagn Ther200925332032719776595
  • RotenLTJohnsonMPForsmoSAssociation between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study)Eur J Hum Genet200917225025718781190
  • FitzpatrickEJohnsonMPDyerTDGenetic association of the activin A receptor gene (ACVR2A) and pre-eclampsiaMol Hum Reprod200915319520419126782
  • RientoKRidleyAJRocks: multifunctional kinases in cell behaviourNat Rev Mol Cell Biol20034644645612778124
  • KandabashiTShimokawaHMiyataKInhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1betaCirculation2000101111319132310725293
  • ArkMYilmazNYaziciGKubatHAktasSRho-associated protein kinase II (rock II) expression in normal and preeclamptic human placentasPlacenta2005261818415664415
  • PetersonHLaivuoriHKerkelaEROCK2 allelic variants are not associated with pre-eclampsia susceptibility in the Finnish populationMol Hum Reprod200915744344919435756
  • Wellcome Trust Case Control ConsortiumGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature2007447714566167817554300
  • FoundsSAConleyYPLyons-WeilerJFJeyabalanAHoggeWAConradKPAltered global gene expression in first trimester placentas of women destined to develop preeclampsiaPlacenta2009301152419027158
  • National Institute of Clinical Excellence (NICE)Hypertension in Pregnancy: The Management of Hypertensive Disorders During PregnancyNICE Clinical Guideline CG107LondonNICE2011 Available from: http://www.nice.org.uk/nicemedia/live/13098/50475/50475.pdf. Accessed January 13, 2012
  • PirmohamedMJamesSMeakinSAdverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patientsBMJ20043297456151915231615
  • HughesARSpreenWRMostellerMPharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utilityPharmacogenomics J20088636537418332899
  • NelsonMRBacanuSAMostellerMGenome-wide approaches to identify pharmacogenetic contributions to adverse drug reactionsPharmacogenomics J200991233318301416
  • KleinTEAltmanRBErikssonNEstimation of the warfarin dose with clinical and pharmacogenetic dataN Engl J Med2009360875376419228618
  • AuffrayCCharronDHoodLPredictive, preventive, personalized and participatory medicine: back to the futureGenome Med2010285720804580
  • PharmGkb [database on the Internet]. Available from: http://www.pharmgkb.org/. Accessed January 6, 2012
  • MoncadaSHiggsAThe L-arginine-nitric oxide pathwayN Engl J Med199332927200220127504210
  • DudzinskiDMMichelTColmanRWThe vascular biology of nitric oxide and nitric oxide synthasesColmanRWClowesAWGoldhaberSZHemostasis and Thrombosis: Basic Prinicples and Clinical Practice5th edPhiladelphia, PALippincott Williams and Wilkins2005653666
  • CookeJPDzauVJNitric oxide synthase: role in the genesis of vascular diseaseAnnu Rev Med1997484895099046979
  • SandrimVCPaleiACMetzgerIFGomesVACavalliRCTanus-SantosJENitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsiaHypertension200852240240718574068
  • GryglewskiRJPalmerRMMoncadaSSuperoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature198632060614544563007998
  • Vasquez-VivarJKalyanaramanBMartasekPSuperoxide generation by endothelial nitric oxide synthase: the influence of cofactorsProc Natl Acad Sci U S A19989516922092259689061
  • MarsdenPAHengHHSchererSWStructure and chromosomal localization of the human constitutive endothelial nitric oxide synthase geneJ Biol Chem19932682317478174887688726
  • MiyaharaKKawamotoTSaseKCloning and structural characterization of the human endothelial nitric-oxide-synthase geneEur J Biochem199422337197267519987
  • SandrimVCPaleiACCavalliRCVascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertensionMol Hum Reprod200915211512019060000
  • CookeGEDoshiABinkleyPFEndothelial nitric oxide synthase gene: prospects for treatment of heart diseasePharmacogenomics20078121723173418086002
  • PereiraTVRudnickiMCheungBMThree endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication biasJ Hypertens20072591763177417762636
  • SilvaPSLacchiniRGomesVde ATanus-SantosJEPharmacogenetic implications of the eNOS polymorphisms for cardiovascular action drugsArq Bras Cardiol2011962e27e3421445464
  • KumasawaKIkawaMKidoyaHPravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse modelProc Natl Acad Sci U S A201110841451145521187414
  • AhmedANew insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complicationsThromb Res2011127Suppl 3S72S7521262447
  • AbeKNakayamaMYoshimuraMIncrease in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the −786T > C polymorphismPharmacogenet Genomics200515532933615864134
  • NagassakiSSertorioJTMetzgerIFBemAFRochaJBTanus-SantosJEeNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitriteFree Radic Biol Med20064171044104916962929
  • Souza-CostaDCSandrimVCLopesLFGerlachRFRegoEMTanus-SantosJEAnti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase geneAtherosclerosis2007193243844416938300
  • KunnasTALehtimakiTLaaksonenREndothelial nitric oxide synthase genotype modulates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET studyJ Mol Med (Berl)2002801280280712483466
  • LiljedahlUKarlssonJMelhusHA microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug responsePharmacogenetics200313171712544508
  • DuleyLHenderson-SmartDJMeherSDrugs for treatment of very high blood pressure during pregnancyCochrane Database Syst Rev20063CD00144916855969
  • LemkeLEMcQueenCAAcetylation and its role in the mutagenicity of the antihypertensive agent hydralazineDrug Metab Dispos19952355595657587931
  • SimELackNWangCJArylamine N-acetyltransferases: structural and functional implications of polymorphismsToxicology2008254317018318852012
  • BarneaERFakihHOelsnerGWalnerSDeCherneyAHNaftolinFEffect of antihypertensive drugs on catechol-O-methyltransferase and monoamine oxidase activity in human term placental explantsGynecol Obstet Invest19862131241303710285
  • AskieLMDuleyLHenderson-SmartDJStewartLAAntiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient dataLancet200736995751791179817512048
  • ShimokawaTSmithWLProstaglandin endoperoxide synthase. The aspirin acetylation regionJ Biol Chem19922671712387123921601897
  • ShantsilaEWatsonTLipGYAspirin resistance: what, why and when?Thromb Res2007119555155417010411
  • AngiolilloDJVariability in responsiveness to oral antiplatelet therapyAm J Cardiol2009103Suppl 327A34A
  • GumPAKottke-MarchantKPoggioEDProfile and prevalence of aspirin resistance in patients with cardiovascular diseaseAm J Cardiol200188323023511472699
  • MuellerMRSalatAStanglPVariable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplastyThromb Haemost1997783100310079308744
  • TantryUSBlidenKPGurbelPAOverestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulationJ Am Coll Cardiol20054691705170916256872
  • GurbelPABlidenKPDiChiaraJEvaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) studyCirculation2007115253156316417562955
  • Cambria-KielyJAGandhiPJPossible mechanisms of aspirin resistanceJ Thromb Thrombolysis2002131495611994560
  • BhattDLAspirin resistance: more than just a laboratory curiosityJ Am Coll Cardiol20044361127112915028379
  • WangTHBhattDLTopolEJAspirin and clopidogrel resistance: an emerging clinical entityEur Heart J200627664765416364973
  • HalushkaMKWalkerLPHalushkaPVGenetic variation in cyclooxygenase 1: effects on response to aspirinClin Pharmacol Ther200373112213012545150
  • Gonzalez-ConejeroRRiveraJCorralJAcunaCGuerreroJAVicenteVBiological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure?Stroke200536227628015604423
  • GoodmanTSharmaPFerroAThe genetics of aspirin resistanceInt J Clin Pract200761582683417391325
  • GoodmanTFerroASharmaPPharmacogenetics of aspirin resistance: a comprehensive systematic reviewBr J Clin Pharmacol200866222223218429969
  • MichelsonADFurmanMIGoldschmidt-ClermontPPlatelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonistsCirculation200010191013101810704169
  • CookeGEBrayPFHamlingtonJDPhamDMGoldschmidt-ClermontPJPlA2 polymorphism and efficacy of aspirinLancet1998351911112539643753
  • CorralJGonzalez-ConejeroRRiveraJOrtunoFAparicioPVicenteVRole of the 807 C/T polymorphism of the alpha2 gene in platelet GP Ia collagen receptor expression and function – effect in thromboembolic diseasesThromb Haemost199981695195610404774
  • BelfortMAThe effect of magnesium sulphate on blood flow velocity in the maternal retina in mild pre-eclampsia: a preliminary colour flow Doppler studyBr J Obstet Gynaecol19929986416451390468
  • SadehMAction of magnesium sulfate in the treatment of preeclampsia-eclampsiaStroke1989209127312752672428
  • DuleyLGulmezogluAMHenderson-SmartDJMagnesium sulphate and other anticonvulsants for women with pre-eclampsiaCochrane Database Syst Rev20032CD00002512804383
  • WitlinAGFriedmanSASibaiBMThe effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trialAm J Obstet Gynecol199717636236279077617
  • AltmanDCarroliGDuleyLDo women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trialLancet200235993211877189012057549
  • LipsitzPJThe clinical and biochemical effects of excess magnesium in the newbornPediatrics19714735015095547870
  • MageeLAAbalosEvon DadelszenPSibaiBEasterlingTWalkinshawSHow to manage hypertension in pregnancy effectivelyBr J Clin Pharmacol201172339440121545480
  • BremerTManAKaskKDiamondCCACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertensionPharmacogenomics20067327127916610939
  • BeitelsheesALNavareHWangDCACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment responseCirc Cardiovasc Genet20092436237020031608
  • LangaeeTYGongYYarandiHNAssociation of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamilClin Pharmacol Ther200781338639117339868
  • BeitelsheesALGongYWangDKCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST)Pharmacogenet Genomics200717971972917700361
  • PacanowskiMAGongYCooper-DehoffRMbeta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertensionClin Pharmacol Ther200884671572118615004
  • LynchAIBoerwinkleEDavisBRPharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertensionJAMA2008299329630718212314
  • The Confidential Enquiry into Maternal and Child Health (CEMACH)Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer – 2003–2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United KingdomLewisGLondonCEMACH2007